Skip to main content

Parkman Healthcare Partners LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1777015 STAMFORD, CT

Position in URGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,944,500
+$991,954 QoQ
Shares Held
275,000
+62.9% QoQ
Ownership
0.564%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Parkman Healthcare Partners LLC holds $362,342,788 across 36 Biotechnology names. URGN ranks #23 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in URGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,944,500 275,000
2025-12-31 $3,952,546 168,768
2025-09-30 $8,031,770 402,595
2025-06-30 $2,420,817 176,702
2025-03-31 $4,348,272 393,153
2024-12-31 $3,939,019 369,861
2024-09-30 $4,413,770 347,541
2024-06-30 $4,605,522 274,465
2024-03-31 $2,762,760 184,184
2023-12-31 $2,632,500 175,500
2023-09-30 $2,035,807 145,311